Tenor Capital Management’s Starling Oncology Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
WAM
DKCM
AGM
Tenor Capital Management's STLNW Position: Q2 2026 in Review
Tenor Capital Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 25,000 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #539.
Tenor Capital Management first reported a position in STLNW in Q2 2020 and has held it in 25 quarters since. The position peaked at $49K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.
- Tenor Capital Management held 25,000 shares of Starling Oncology Warrant worth $1.02K as of Q2 2026.
- Tenor Capital Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
- Starling Oncology Warrant made up ﹤0.01% of Tenor Capital Management's portfolio in Q2 2026, its #539 holding.
- Tenor Capital Management first reported a position in Starling Oncology Warrant in Q2 2020 and has held it in 25 quarters since.
- Tenor Capital Management's Starling Oncology Warrant position peaked at $49K in Q4 2020.
- 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.
Based on Tenor Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.